Bookmark and Share

Compound Summary for: CID 5388937

quinupristin

Also known as: RP 57669; RP-57669; Antibiotic RP 57669; Quinupristin [USAN:INN]; Quinupristine [INN-French]; Quinupristinum [INN-Latin]; UNII-23OW28RS7P
Molecular Formula: C53H67N9O10S   Molecular Weight: 1022.21838   InChIKey: WTHRRGMBUAHGNI-LCYNINFDSA-N
Quinupristin/dalfopristin is a combination of two antibiotics used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis. The combination of the two components acts synergistically and is more effective in vitro than each component alone.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _